CRL

Charles Riv Labs Intl Inc

• TipRanks·1h ago

  J.P. Morgan Sticks to Its Buy Rating for Charles River Labs (CRL)

• Dow Jones·3d ago

  Charles River Labs Price Target Raised to $340.00/Share From $300.00 by Morgan Stanley

• Dow Jones·3d ago

  Charles River Labs Is Maintained at Overweight by Morgan Stanley

• TipRanks·4d ago

  Charles River announces collaboration with Magellan Stem Cells

• TipRanks·5d ago

  Charles River price target raised to $340 from $300 at Morgan Stanley

• Dow Jones·10/09 20:34

  Illumina Inc. Stock Rallies 5.1%, Outperforms Peers

• NASDAQ·10/07 14:40

  PGNY or CRL: Which Is the Better Value Stock Right Now?

• TipRanks·10/07 01:48

  RBC Capital Remains a Buy on Charles River Labs (CRL)

• Dow Jones·10/06 20:33

  Illumina Inc. Stock Slides 6.9%, Underperforms Peers

• Seeking Alpha·10/06 12:19

  Charles River Labs and Autolomous launch Apollo Orchestrate for digital lab execution

• TipRanks·10/06 12:05

  Charles River, Autolomous announce launch of Apollo Orchestrate

• NASDAQ·10/06 07:37

  Biotech Stocks At 52-Week Highs - PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%

• Dow Jones·10/05 20:33

  Charles River Laboratories International Inc. Stock Rises 7.1%, Outperforms Peers

• MarketWatch·10/05 20:30

  Charles River Laboratories International Inc. stock outperforms competitors on strong trading day

• Dow Jones·10/05 16:29

  Charles River Laboratories on Track for Highest Close Since February 2022 -- Data Talk